Journals / Meandros Medical And Dental Journal / 2008 / Cilt: 9 Sayı: 2

Gastrointestinal System Involvement and Its Treatment in ChildrenWith Henoch-Schonlein Purpura

ÇOCUKLARDA HENOCH SCHÖNLEİN PURPURASI, GASTROİNTESTİNAL SİSTEM TUTULUMU VE TEDAVİSİ

Pages
17–20
Publication Date
2008-08-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: We found gastrointestinal involvement in about 60% of children with Henoch-Schönlein purpura and steroid treatment in cases with severe involvement was effective.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: Henoch Schönlein purpura is an IgA-mediated autoimmune vasculitis of children.
📊
Key Findings & Data:Materials and Methods: Aretrospective study of 31 patients diagnosed with Henoch-Schönlein purpura between December 2005 and December 2007 was conducted.
💡
Conclusion & Impact:Conclusion: We found gastrointestinal involvement in about 60% of children with Henoch-Schönlein purpura and steroid treatment in cases with severe involvement was effective.
🔬Design:Research Article
📍Scope:2005 Verileri
⚙️Variables:Henoch Schönlein purpurası · çocukluk çağı · gastrointestinal tutulum

Abstract

Purpose: Henoch Schönlein purpura is an IgA-mediated autoimmune vasculitis of children. It often presents with symptoms including purpuric rash, abdominal pain, renal involvement or arthritis. Abdominal pain is a frequent symptom in children with gastrointestinal involvement. We sought to evaluate gastrointestinal involvement in children with Henoch Schönlein purpura and the efficiency of steroid treatment of this condition. Materials and Methods: Aretrospective study of 31 patients diagnosed with Henoch-Schönlein purpura between December 2005 and December 2007 was conducted. Low dose steroid was used in children with gastrointestinal involvement. Results: Of the 31 patients, 3 (9.6%) had mild abdominal pain, 5(16.1%) colicy abdominal pain and 5 (16.%) suffered either overt gastrointestinal bleeding or had positive stool occult blood. Conclusion: We found gastrointestinal involvement in about 60% of children with Henoch-Schönlein purpura and steroid treatment in cases with severe involvement was effective.

Özet

Amaç:Henoch-Schönlein purpurası çocukluk çağının IgAaracılığı ile oluşan otoimmün vaskülitidir. Genelliklepurpurik döküntü, karın ağrısı, artrit veya hematüri ile ortaya çıkmaktadır. Gastrointestinal tutulumlu çocuklardakarın ağrısı sık bir yakınmadır. Bu çalışmada; Henoch-Schönlein purpuralı çocuklarda gastrointestinal sistemtutulumunu ve onun steroidle tedavisini araştırdık.Gereç ve Yöntem:Aralık 2005 ileAralık 2007 arasındaki iki yıllık sürede Henoch-Schönlein purpurası tanısıylaizlenen hastalar çalışma grubunu oluşturdu. Gastrointestinal tutulumu olan hastalara düşük doz steroid kullanıldı.Bulgular:Toplam 31 hastanın üçünde (%9,6) hafif, beşinde (%16,1) ağır karın ağrısı, beşinde (%16,1) isegaitada belirgin ve/veya gizli kanama saptandı.Sonuç: Henoch-Schönlein purpuralı çocuklarda gastrointestinal tutulumu yaklaşık %60 sıklıkta ve bu sisteminağır tutulumunun tedavisinde steroidi etkili bulduk

🔖

Cite This Article

TABEL, Y., ÇETİN, M. (2008). Gastrointestinal System Involvement and Its Treatment in ChildrenWith Henoch-Schonlein Purpura. Meandros Medical And Dental Journal, Cilt: 9 Sayı: 2, 17–20. https://ajindex.com/articles/1002812

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Coppo R, Amore A. Henoch-Schonlein purpura. In: Avner AD, Harmon WE, Niaudet P, editors. Pediatric Nephrology, 5th ed. Philadelphia: Lippincott Williams&Wilkins 2004: 851-63
  2. Cassidy JT, Petty RE. Henoch-Schönlein purpura. Textbook of Pediatric Rheumatology. Tokyo: W.B. Saunders Company, 1995: 384-88
  3. Mir S, Yavascan O, Mutlubas F, Yeniay B, Sonmez F. Clinical outcome in children with Henoch-Schönlein nephritis. Pediatr Nephrol 2007; 22: 6470
  4. Chang WL, Yang YH, Lin YT, Chiang BL. Gastrointestinal manifestations in Henoch-Schönlein purpura: a review of 261 patients. Acta Paediatr 2004; 93: 1427-31
  5. Cakir M, Orhan F, Mungan I, et al. Henoch-Schönlein purpura in north-eastern Turkey. Ann Trop Paediatr 2006; 26(1): 59-65
  6. Aksu N, Akın M, Yavaşcan Ö, Erdoğan H, ve ark. Henoch-Schönlein sendromlu çocuklarda gastrointestinal sistemin endoskopi ve radyolojik yöntemlerle değerlendirilmesi. Nefroloji Dergisi 2001; 10(2); 98102
  7. Lin SJ, Chao HC, Huang JL. Gastrointestinal involvement as the initial manifestation in children with Henoch-Schönlein purpura; clinical analysis of 27 cases. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi. 1998; 39(3):18690
  8. Shin JI, Lee JS, Chung KS. Dapsone therapy for Henoch-Schonlein purpura. Arch Dis Child 2006; 91(8): 714
  9. Shimomura N, Kawai K, Watanabe S, Katsuumi K, Ito M. Adult Henoch-Schönlein purpura with severe abdominal pain treated with dapsone and factor XIII concentrate. J Dermatol 2005; 32(2):124-7
  10. Mills JA, Michel BA, Bloch DA, Calabrese LH, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum 1990; 33: 1114-21
  11. Akalın F, Çalışkan S, Sever L, ve ark. HenochSchönlein purpuralı çocuklarda klinik bulgular ve akut faz reaktanları ilişkisi. İstanbul Çocuk Kliniği Dergisi 1993; 28: 106-11
  12. Gülcan EM. Henoch-Schönlein purpuralı çocuklarda gastrointestinal sistem tutulumunun klinik ve laboratuar bulguları. Bakırköy Tıp Dergisi 2007; 3(3): 94-100
  13. Gardner-Medwin JMM, Dolezalova P, Cummins C, Southwood TR. Incidence of Henoch-Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet 2002; 360: 1197-1202
  14. Ebert EC. Gastrointestinal manifestations of HenochSchonlein purpura. Dig Dis Sci 2008; 53(8): 2011-9
  15. Schwab J, Benya E, Lin R, Majd K. Contrast enema in children with Henoch-Schonlein purpura. J Pediatr Surg 2005; 40:1221-3
  16. Trapani S,